Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
134 studies found for:    glioblastoma | Open Studies | Phase 2
Show Display Options
Rank Status Study
1 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
2 Recruiting Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma;   Recurrent Glioblastoma;   Brain Tumor
Intervention: Drug: Tesevatinib
3 Recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Condition: Glioblastoma
Interventions: Drug: Temozolomide;   Drug: Neratinib;   Drug: CC-115;   Drug: Abemaciclib
4 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
5 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide
6 Recruiting Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: SRT to the resection cavity
7 Recruiting uPAR-PET/MRI in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: One injection of 68Ga-NOTA-AE105;   Device: PET/MRI
8 Recruiting Trial of Hypofractionated Radiation Therapy for Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Hypofractionated radiation therapy;   Radiation: Standard radiation therapy
9 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
10 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia;   Glioblastoma
Intervention: Drug: Romiplostim
11 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
12 Recruiting Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: gamma knife radiosurgery (15 Gy to 50% isodose)
13 Not yet recruiting Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
Condition: Glioblastoma Multiforme
Intervention: Drug: levetiracetam
14 Recruiting Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Interventions: Radiation: Stereotactic hypofractionated RT 5x5Gy;   Radiation: Stereotactic hypofractionated RT 5x7Gy
15 Recruiting Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Atorvastatin;   Drug: Temozolomide;   Radiation: Radiotherapy
16 Recruiting Regorafenib in Relapsed Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Regorafenib;   Drug: Lomustine
17 Recruiting Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: Sunitinib;   Drug: Temozolomide;   Radiation: Radiation Therapy
18 Recruiting A Study of Abemaciclib in Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Abemaciclib;   Procedure: Surgery
19 Recruiting Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Ponatinib
20 Recruiting Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Condition: Glioblastoma
Interventions: Drug: Pembrolizumab;   Biological: HSPPC-96;   Drug: Temozolomide;   Other: Placebo;   Radiation: radiation treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.